Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
BT-20 | 17-AAG | 0.0001 | uM | 8 | 2500.00 | 1344.63 | 4339.00 | 3879.25 | 1.1185 | 1.1520 |
BT-20 | Erlotinib | 0.031623 | uM | 8 | 2500.00 | 1344.63 | 4017.00 | 3879.25 | 1.0355 | 1.0462 |
BT-20 | Lapatinib | 1 | uM | 8 | 2500.00 | 1344.63 | 3937.00 | 3879.25 | 1.0149 | 1.0194 |
BT-20 | Linsitinib | 10 | uM | 8 | 2500.00 | 1344.63 | 3576.00 | 3879.25 | 0.9218 | 0.8963 |
BT-20 | Erlotinib | 3.1623 | uM | 8 | 2500.00 | 1344.63 | 3423.00 | 3879.25 | 0.8824 | 0.8428 |
BT-20 | Erlotinib | 10 | uM | 8 | 2500.00 | 1344.63 | 3040.00 | 3879.25 | 0.7837 | 0.7052 |
BT-20 | Linsitinib | 0.31623 | uM | 8 | 2500.00 | 1344.63 | 3856.00 | 3879.25 | 0.9940 | 0.9922 |
BT-20 | Linsitinib | 0.0033113 | uM | 8 | 2500.00 | 1344.63 | 4050.00 | 3879.25 | 1.0440 | 1.0572 |
BT-20 | 17-AAG | 0.01 | uM | 8 | 2500.00 | 1344.63 | 2600.00 | 3879.25 | 0.6702 | 0.5394 |
BT-20 | Lapatinib | 3.1623 | uM | 8 | 2500.00 | 1344.63 | 3244.00 | 3879.25 | 0.8362 | 0.7792 |
BT-20 | 17-AAG | 0.001 | uM | 8 | 2500.00 | 1344.63 | 4405.00 | 3879.25 | 1.1355 | 1.1734 |
BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 4038.00 | 3879.25 | 1.0409 | 1.0532 | |
BT-20 | 17-AAG | 0.0031623 | uM | 8 | 2500.00 | 1344.63 | 3670.00 | 3879.25 | 0.9461 | 0.9288 |
BT-20 | Linsitinib | 1 | uM | 8 | 2500.00 | 1344.63 | 3854.00 | 3879.25 | 0.9935 | 0.9915 |
BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3737.00 | 3879.25 | 0.9633 | 0.9517 | |
BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3402.00 | 3879.25 | 0.8770 | 0.8354 | |
BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 2956.00 | 3879.25 | 0.7620 | 0.6742 | |
BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3325.00 | 3879.25 | 0.8571 | 0.8081 | |
BT-20 | Linsitinib | 19.9526 | uM | 8 | 2500.00 | 1344.63 | 2357.00 | 3879.25 | 0.6076 | 0.4437 |
BT-20 | Linsitinib | 3.1623 | uM | 8 | 2500.00 | 1344.63 | 3788.00 | 3879.25 | 0.9765 | 0.9691 |
BT-20 | Lapatinib | 0.0033113 | uM | 8 | 2500.00 | 1344.63 | 3846.00 | 3879.25 | 0.9914 | 0.9888 |
BT-20 | Erlotinib | 0.0033113 | uM | 8 | 2500.00 | 1344.63 | 4004.00 | 3879.25 | 1.0322 | 1.0418 |
BT-20 | Linsitinib | 0.1 | uM | 8 | 2500.00 | 1344.63 | 3653.00 | 3879.25 | 0.9417 | 0.9229 |
BT-20 | Lapatinib | 0.1 | uM | 8 | 2500.00 | 1344.63 | 3986.00 | 3879.25 | 1.0275 | 1.0358 |
BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 4052.00 | 3879.25 | 1.0445 | 1.0578 |